These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36148507)

  • 21. Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
    Liang L; Shi R; Liu X; Yuan X; Zheng S; Zhang G; Wang W; Wang J; England K; Via LE; Cai Y; Goldfeder LC; Dodd LE; Barry CE; Chen RY
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1145-1149. PubMed ID: 28911359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of perforin in CD8
    Jiang H; Gong H; Zhang Q; Gu J; Liang L; Zhang J
    J Thorac Dis; 2017 May; 9(5):1353-1360. PubMed ID: 28616288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study.
    Yoon YS; Jung JW; Jeon EJ; Seo H; Ryu YJ; Yim JJ; Kim YH; Lee BH; Park YB; Lee BJ; Kang H; Choi JC
    Thorax; 2017 Mar; 72(3):263-270. PubMed ID: 27553224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    Tuberculosis (Edinb); 2016 Dec; 101():191-200. PubMed ID: 27865391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study.
    Wang Q; Ma A; Han X; Zhao S; Cai J; Ma Y; Zhao J; Wang Y; Dong H; Zhao Z; Wei L; Yu T; Chen P; Schouten EG; Kok FJ; Kapur A
    PLoS One; 2013; 8(12):e82660. PubMed ID: 24367535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining interferon-
    Lv D; Liu Y; Guo F; Wu A; Mo Y; Wang S; Chu J
    J Int Med Res; 2020 Jun; 48(6):300060520925660. PubMed ID: 32527178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological host responses as surveillance and prognostic markers in tubercular infections.
    Waghmare PJ; Lende T; Goswami K; Gupta A; Gupta A; Gangane N; Kumar S
    Int J Mycobacteriol; 2019; 8(2):190-195. PubMed ID: 31210165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study.
    Mukhtar F; Butt ZA
    PLoS One; 2018; 13(11):e0207148. PubMed ID: 30408109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil.
    Almeida-Junior JL; Gil-Santana L; Oliveira CA; Castro S; Cafezeiro AS; Daltro C; Netto EM; Kornfeld H; Andrade BB
    PLoS One; 2016; 11(4):e0153590. PubMed ID: 27078026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Spectrum and Medical Comorbidities in Tuberculosis: A Hospital-Based Study in Northeast India.
    Bhattacharya P; Talukdar K; Barman B; Jamil M; Phukan P; Mobing H; War G; Nonglait PL; Murti S; Prithviraj K; Sangma B
    Cureus; 2020 Sep; 12(9):e10580. PubMed ID: 33110716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and design of a randomized controlled trial of the effect of retinol and vitamin D supplementation on treatment in active pulmonary tuberculosis patients with diabetes.
    Wang Q; Ma A; Bygbjerg IC; Han X; Liu Y; Zhao S; Cai J
    BMC Infect Dis; 2013 Feb; 13():104. PubMed ID: 23442225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
    Kang WL; Wang GR; Wu MY; Yang KY; Er-Tai A; Wu SC; Geng SJ; Li ZH; Li MW; Li L; Tang SJ
    Chin Med J (Engl); 2018 Feb; 131(3):268-275. PubMed ID: 29363640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative proteomics reveals plasma protein profile and potential pathways in pulmonary tuberculosis patients with and without diabetes.
    He X; Wang Y; Yang Y; He Q; Sun L; Jin J
    Tuberculosis (Edinb); 2023 Dec; 143():102424. PubMed ID: 37871493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohort profile: the diabetes-tuberculosis treatment outcome (DITTO) study in Pakistan.
    Mukhtar F; Butt ZA
    BMJ Open; 2016 Dec; 6(12):e012970. PubMed ID: 27913560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarkers Involved in Pulmonary Tuberculosis and Pulmonary Tuberculosis-Complicated Diabetes.
    Wang Y; He X; Zheng D; He Q; Sun L; Jin J
    Microbiol Spectr; 2023 Aug; 11(4):e0057723. PubMed ID: 37522815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study.
    Mesquita ED; Gil-Santana L; Ramalho D; Tonomura E; Silva EC; Oliveira MM; Andrade BB; Kritski A;
    BMC Infect Dis; 2016 Aug; 16():368. PubMed ID: 27494953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoring.
    Moideen K; Nathella PK; Madabushi S; Renji RM; Srinivasan P; Ahamed SF; Rajkumar H; Bethunaickan R; Babu S
    Cytokine; 2023 Aug; 168():156238. PubMed ID: 37276815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.